medigraphic.com
ISSN 0035-0052 (Impreso)

2017, Número S1

Rev Mex Pediatr 2017; 84 (S1)


Edulcorantes no calóricos en la edad pediátrica: análisis de la evidencia científica

Wakida-Kuzunoki GH, Aguiñaga-Villaseñor RG, Avilés-Cobián R, Baeza-Bacab MA, Cavagnari BM, del Castillo-Ruíz V, Hernández-Aguilar JC, López-García R, Martínez-Ramos MA, Martínez-Rodríguez N, Molina-Seguí F, Padrón-Martínez MM, Santiago-Lagunes LM, Velasco-Hidalgo L, Vilchis-Gil J, Villasis-Keever MÁ, Xochihua-Díaz L, Laviada-Molina H

Idioma: Español
Referencias bibliográficas: 98
Paginas: 3-23
Archivo PDF: 549.32 Kb.


RESUMEN

Los edulcorantes no calóricos son aditivos alimentarios cuya función tecnológica es proporcionar sabor dulce a los alimentos, pero con un valor energético nulo o muy bajo. Existen dudas entre los consumidores sobre los riesgos para la salud que podrían estar asociados al uso de edulcorantes no calóricos. En la comunidad pediátrica hay interés en el cuerpo de investigación publicado que evalúa la seguridad y el posible uso de estos aditivos en niños sanos y en algunas situaciones patológicas. Después de una extensa revisión de la literatura y clasificación de la evidencia disponible, en este artículo, un grupo de trabajo intenta proporcionar a los profesionales de la salud, en particular a los pediatras, conclusiones basadas en la evaluación y la calidad de la literatura científica actual. El papel de los edulcorantes no calóricos en la infancia se integró después de revisar una serie de temas de interés que fueron objeto del análisis crítico del grupo de trabajo: su seguridad toxicológica, el impacto potencial en la obesidad y en el balance energético, la compensación calórica, en la diabetes mellitus, carcinogenicidad, teratogenicidad, alergias, fenilcetonuria, efectos gastrointestinales, metabolismo mineral y caries dental.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Food and Agriculture Organization of the United Nations/World Health Organization. Class Names and the International System for Food Additives (CAC/GL 36-1989). Codex Alimentarius. [Internet]. 2015 [Citado el: 12 de 10 de 2016.] Available in: http://www.fao.org/fao-who-codexalimentarius/shproxy/en/?lnk=1&url=https%253A%252F%252Fworkspace.fao.org%252Fsites%252Fcodex%252FStandards%252FCAC%2BGL%2B36-1989%252FCXG_036e.pdf.

  2. Codex Alimentarius. General Standard for Food Additives. Codex Stan 192-1995. [Internet] 1995. [Citado el: 12 de 10 de 2016.] Available in: http://www.fao.org/fao-who-codexalimentarius/sh-proxy/en/?lnk=1&url=https%253A%252F%252Fworkspace.fao.org%252Fsites%252Fcodex%252FStandards%252FCODEX%2BSTAN%2B192-1995%252FCXS_192e.pdf.

  3. United States Food and Drug Administration (FDA). Additional information about high intensity sweeteners permitted for use in food in the United States. www.fda.gov. [Internet] [Citado el: 19 de 2 de 2016.] Available in: www.fda.gov/Food Ingredients Packaging Labeling/FoodAdditivesIngredients/ucm397725.htm.

  4. FAO/WHO Joint Expert Committe for Food Additives and Contaminants. Evaluación de los riesgos asociados con las sustancias químicas (JECFA). www.fao.org. [En línea] Food andAgriculture Organization of the United Nations. [Citado el: 14 de 12 de 2015.] Disponible en: http://www.fao.org/food/food-safety-quality/scientific-advice/jecfa/es/.

  5. Organization for Economic Co-operation and Development. OECD Guidelines for th eTesting of Chemicals. OECD.org. [En línea] OECD. [Citado el: 17 de 12 de 2013.] http://www.oecd.org/chemicalsafety/testing/oecdguidelinesforthetestingofchemicals.htm.

  6. European Commission Scientific Committee on Food. Guidance on subnissions for food additive evaluations by the scientific committee on food. SCF/CS/ADD/GEN/26 Final. Brussels: European Commission, 2001.

  7. Joint FAO/WHO Expert Committee of Food Additives (JECFA). Toxicological evaluation of certain food additives with a review of general principles and specifications. Geneva: World Heath Organization, 1974.

  8. O’Brien NL. Alternative sweeteners: an overview. Alternative Sweeteners. Boca Raton: CRC Press, 2012, pp. 1-10.

  9. Food U, Administration D. Additional information about high-intensity sweeteners permitted for use in food in the United States. 2015.

  10. Shwide-Slavin C, Swift C, Ross T. Nonnutritive sweeteners: where are we today? Diabetes Spectrum. 2012; 25(2): 104-110.

  11. Mayo Clinic. Artificial Sweeteners and other sugar substitutes. www.mayoclinic.org. [En línea] Mayo Clinic. [Citado el: 21 de 2 de 2016.] Available in: http://www.mayoclinic.org/healthy-living/nutrition-and-healthy-eating/in-depth/artificial-sweeteners/art-20046936.

  12. Food Safety Authority of Ireland (FSAI). Legislation, intake and usage of food additives in Ireland. Dublin: FSAI, 2001.

  13. Commission. CA. Cuestions remitidas al Comité por la Comisión del Codex Alimentarius y otros Comités y Grupos Especiales del Códex. Rome: Food and Agriculture Organization of the United Nations, 2012.

  14. International Programme on Chemical Safety (IPCHS). Principles for the safety assessment of food additives and contaminants in food. [En línea] [Citado el: 19 de 2 de 2016.] Available in: http://www.inchem.org/documents/ehc/ehc/ehc70.htm#PartNumber:2.

  15. National Cancer Institute. Edulcorantes artificiales y el cáncer. www.cancer.gov. [En línea] National Cancer Institute. [Citado el: 13 de 1 de 2016.] Available in: www.cancer.gov/espanol/cancer/causasprevencion/riesgo/dieta/hojainformativaedulcorantesartificiale

  16. Institute NC. Edulcorantes artificiales y el cáncer. www.cancer.gov. [En línea] National Cancer Institute. [Citado el: 13 de 1 de 2016.] Disponible en: www.cancer.gov/espanol/cancer/causasprevencion/riesgo/dieta/hojainformativaedulcorantesartificiales.

  17. Fitch C, Keim KS; Academy of Nutrition and Dietetics. Position of the Academy of Nutrition and Dietetics: use of nutritive and nonnutritive sweeteners. J Acad Nutr Diet. 2012; 112(5): 739-758.

  18. Diario Oficial de la Federación. Ley General de Salud. DOF. 12 de 2013.

  19. Reglamento de Control Sanitario de Productos y Servicios. DOF. 11 de 2012.

  20. Diario Oficial de la Federación (DOF). ACUERDO por el que se determinan los aditivos y coadyuvantes en alimentos, bebidas y suplementos alimenticios, su uso y idisposiciones sanitarias. DOF. 16 de 7 de 2012.

  21. Diario Oficial de la Federación (DOF). Norma Oficial Mexicana NOM-131-SSA1-2012, Productos y Servicios. Fórmulas para lactantes, de continuación y para necesidades especiales de nutrición, alimentos y bebidas no alcohólicas para lactantes y niños de corta edad. Disposiciones y especificaciones. 10 de 09 de 2012.

  22. Hernández-Ávila M, Rivera-Dommarco J, Shamah-Levy T, Cuevas-Nasu L, Gómez-Acosta L, Gaona-Pineda E. Encuesta Nacional de Salud y Nutrición de Medio Camino 2016. Cuernavaca, Morelos, México: Instituto Nacional de Salud Pública. 2016.

  23. Organization WH. Guideline: sugars intake for adults and children. World Health Organization; 2015.

  24. Sylvetsky A, Rother KI, Brown R. Artificial sweetener use among children: epidemiology, recommendations, metabolic outcomes, and future directions. Pediatr Clin North Am. 2011; 58(6): 1467-1480.

  25. Gil-Campos M, González MS, Martín JD, Comité de la Nutrición de la Asociación de Pediatría Española. Uso de azúcares y edulcorantes en la alimentación del niño. Recomendaciones del Comité de Nutrición de la Asociación Española de Pediatría. An Pediatr. 2015; 83(5): 353.e1.7.

  26. Aguayo-Albasini JL, Flores-Pastor B, Soria-Aledo V. Sistema GRADE: clasificación de la calidad de la evidencia y graduación de la fuerza de la recomendación. Cir Esp. 2014; 92(2): 82-88.

  27. Fowler SP, Williams K, Resendez RG, Hunt KJ, Hazuda HP, Stern MP. Fueling the obesity epidemic? Artificially sweetened beverage use and long‐term weight gain. Obesity. 2008; 16(8): 1894-900.

  28. Nettleton JA, Lutsey PL, Wang Y, Lima JA, Michos ED, Jacobs DR. Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care. 2009; 32(4): 688-694.

  29. Ruanpeng D, Thongprayoon C, Cheungpasitporn W, Harindhanavudhi T. Sugar and artificially sweetened beverages linked to obesity: a systematic review and meta-analysis. QJM. 2017; 110(8): 513-520.

  30. Reid AE, Chauhan BF, Rabbani R, Lys J, Copstein L, Mann A et al. Early exposure to nonnutritive sweeteners and long-term metabolic health: a systematic review. Pediatrics. 2016; 137: e20153603.

  31. Foreyt J, Kleinman R, Brown RJ, Lindstrom R. The use of low-calorie sweeteners by children: implications for weight management. J Nutr. 2012; 142(6): 1155S-1162S.

  32. Riobó SP, Sierra PR, Soldo RJ. Low and no calorie sweeteners (LNCS); myths and realities. Nutr Hosp. 2014; 30(Suppl. 2e) 49-55.

  33. Serra ML, Serván PR, Cortés SB, Navarro AA, Bartrina JA, Vargas EF et al. Chinchón declaration; decalogue on low-and no-calorie sweeteners (LNCS). Nutr Hosp. 2014; 29(4): 719-734.

  34. Gardner C, Wylie-Rosett J, Gidding SS, Steffen FL, Johnson FR, Reader D et al. Nonnutritive sweeteners: Current use and health perspectives - A scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2012; 35: 1798-1808.

  35. Rogers PJ, Hogenkamp PS, De Graaf C, Higgs S, Lluch A, Ness AR et al. Does low-energy sweetener consumption affect energy intake and body weight? A systematic review, including meta-analyses, of the evidence from human and animal studies. Int J Obes (Lond). 2016; 40(3): 381-394.

  36. Peters JC, Beck J, Cardel M, Wyatt HR, Foster GD, Pan Z et al. The effects of water and non-nutritive sweetened beverages on weight loss and weight maintenance: A randomized clinical trial. Obesity (Silver Spring). 2016; 24(2): 297-304.

  37. Madjd A, Taylor MA, Delavari A, Malekzadeh R, Macdonald IA, Farshchi HR. Effects on weight loss in adults of replacing diet beverages with water during a hypoenergetic diet: a randomized, 24-wk clinical trial. Am J Clin Nutr. 2015; 102(6): 1305-1312.

  38. de Ruyter JC, Katan MB, Kuijper LDJ, Liem DG, Olthof MR. The effect of sugar-free versus sugar-sweetened beverages on satiety, liking and wanting: an 18 month randomized double-blind trial in children. PLoS ONE. 2013; 8(10).

  39. Taljaard C, Covic NM, van Graan AE, Kruger HS, Smuts CM, Baumgartner J et al. Effects of a multi-micronutrient-fortified beverage, with and without sugar, on growth and cognition in South African schoolchildren: a randomised, double-blind, controlled intervention. Br J Nutr. 2013; 110(12): 2271-2284.

  40. Birch LL, McPhee L, Sullivan S. Children’s food intake following drinks sweetened with sucrose or aspartame: time course effects. Physiol Behav. 1989; 45(2): 387-395.

  41. Anderson GH, Saravis S, Schacher R, Zlotkin S, Leiter LA. Aspartame: effect on lunch-time food intake, appetite and hedonic response in children. Appetite. 1989; 13(2): 93-103.

  42. Mattes RD, Popkin BM. Nonnutritive sweetener consumption in humans: effects on appetite and food intake and their putative mechanisms. Am J Clin Nutr. 2009; 89(1): 1-14.

  43. Rogers PJ, Carlyle JA, Hill AJ, Blundell JE. Uncoupling sweet taste and calories: comparison of the effects of glucose and three intense sweeteners on hunger and food intake. Physiol Behav. 1988; 43(5): 547-552.

  44. Gougeon R, Spidel M, Lee K, Field CJ. Canadian Diabetes Association National Nutrition Committee technical review: Non-nutritive intense sweeteners in diabetes management. Canadian Journal of Diabetes. 2004; 28: 385-399.

  45. Wiebe N, Padwal R, Field C, Marks S, Jacobs R, Tonelli M. A systematic review on the effect of sweeteners on glycemic response and clinically relevant outcomes. BMC Medicine. 2011; 9: 123.

  46. Mathieu-Huart A, De Lentdecker C, Riviere G, Sissoke F, Rousselle C. French Agency for Food, Environmental and Occupational Health and Safety (ANSES) health reference values (RV). Archives Des Maladies Professionnelles Et De L Environnement. 2014; 75(3): 292-301.

  47. EFSA N. Scientific opinion on the substantiation of health claims related to intense sweeteners and contribution to the maintenance or achievement of a normal body weight (ID 1136, 1444, 4299), reduction of post-prandial glycaemic responses (ID 4298), maintenance of normal blood glucose concentrations (ID 1221, 4298), and maintenance of tooth mineralisation by decreasing tooth demineralisation (ID 1134, 1167, 1283) pursuant to Article 13 (1) of Regulation (EC) No 1924/2006. EFSA Journal. 2011; 9: 2229.

  48. Franz MJ, Powers MA, Leontos C, Holzmeister LA, Kulkarni K, Monk A et al. The evidence for medical nutrition therapy for type 1 and type 2 diabetes in adults. J Am Diet Assoc. 2010; 110(12): 1852-1889.

  49. Fagherazzi G, Vilier A, Sartorelli DS, Lajous M, Balkau B, Clavel-Chapelon F. Consumption of artificially and sugar-sweetened beverages and incident type 2 diabetes in the Etude Epidémiologique auprès des femmes de la Mutuelle Générale de l’Education Nationale-European Prospective Investigation into Cancer and Nutrition cohort. Am J Clin Nutr. 2013; 97(3): 517-523.

  50. Imamura F, O’Connor L, Ye Z, Mursu J, Hayashino Y, Bhupathiraju SN et al. Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. BMJ. 2015; 351: h3576.

  51. Romo-Romo A, Aguilar-Salinas CA, Brito-Córdova GX, Díaz RAG, Valentín DV, Almeda-Valdes P. Effects of the non-nutritive sweeteners on glucose metabolism and appetite regulating hormones: Systematic review of observational prospective studies and clinical trials. PloS One. 2016; 11(8): e0161264.

  52. Anton SD, Martin CK, Han H, Coulon S, Cefalu WT, Geiselman P et al. Effects of stevia, aspartame, and sucrose on food intake, satiety, and postprandial glucose and insulin levels. Appetite. 2010; 55(1): 37-43.

  53. Okuno G, Kawakami F, Tako H, Kashihara T, Shibamoto S, Yamazaki T et al. Glucose tolerance, blood lipid, insulin and glucagon concentration after single or continuous administration of aspartame in diabetics. Diabetes Res Clin Pract. 1986; 2(1): 23-27.

  54. Härtel B, Graubaum H, Schneider B. The influence of sweetener solutions on the secretion of insulin and the blood glucose level. Ernährungsumschau. 1993; 40(4): 152-155.

  55. Barriocanal LA, Palacios M, Benitez G, Benitez S, Jimenez JT, Jimenez N et al. Apparent lack of pharmacological effect of steviol glycosides used as sweeteners in humans. A pilot study of repeated exposures in some normotensive and hypotensive individuals and in Type 1 and Type 2 diabetics. Regul Toxicol Pharmacol. 2008; 51(1): 37-41.

  56. Maki KC, Curry LL, Reeves MS, Toth PD, McKenney JM, Farmer MV et al. Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus. Food Chem Toxicol. 2008; 46 Suppl 7: S47-53.

  57. Tate DF, Turner-McGrievy G, Lyons E, Stevens J, Erickson K, Polzien K et al. Replacing caloric beverages with water or diet beverages for weight loss in adults: main results of the Choose Healthy Options Consciously Everyday (CHOICE) randomized clinical trial. Am J Clin Nutr. 2012; 95(3): 555-563.

  58. Grotz VL, Henry RR, McGill JB, Prince MJ, Shamoon H, Trout JR et al. Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes. J Am Diet Assoc. 2003; 103(12): 1607-1612.

  59. Colagiuri S, Miller JJ, Edwards RA. Metabolic effects of adding sucrose and aspartame to the diet of subjects with noninsulin-dependent diabetes mellitus. Am J Clin Nutr. 1989; 50(3): 474-478.

  60. Nehrling JK, Kobe P, McLane MP, Olson RE, Kamath S, Horwitz DL. Aspartame use by persons with diabetes. Diabetes Care. 1985; 8(5): 415-417.

  61. Chantelau EA, Gosseringer G, Sonnenberg GE, Berger M. Moderate intake of sucrose does not impair metabolic control in pump-treated diabetic out-patients. Diabetologia. 1985; 28(4): 204-207.

  62. Calzada-León R, Ruiz-Reyes ML , Altamirano-Bustamante N, Padrón-Martínez MM. Características de los edulcorantes no calóricos y su uso en niños. Acta Pediatr Mex. 2014; 34(3): 141-153.

  63. Gurney JG, Pogoda JM, Holly EA, Hecht SS, Preston-Martin S. Aspartame consumption in relation to childhood brain tumor risk: results from a case-control study. J Natl Cancer Inst. 1997; 89(14): 1072-1074.

  64. Bunin GR, Kushi LH, Gallagher PR, Rorke-Adams LB, McBride ML, Cnaan A. Maternal diet during pregnancy and its association with medulloblastoma in children: a children’s oncology group study (United States). Cancer Causes Control. 2005; 16(7): 877-891.

  65. Bernardo WM, Simões RS, Buzzini RF, Nunes VM, Glina F. Adverse effects of the consumption of artificial sweeteners-systematic review. Rev Assoc Med Bras (1992). 2016; 62(2): 120-122.

  66. Authority E. Statement of EFSA on the scientific evaluation of two studies related to the safety of artificial sweeteners. EfSA Journal. 2011; 9: 16.

  67. Soffritti M, Belpoggi F, Tibaldi E, Degli Esposti D, Lauriola M. Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats. Environ Health Perspect. 2007; 115(9): 1293-1297.

  68. Soffritti M, Belpoggi F, Manservigi M, Tibaldi E, Lauriola M, Falcioni L et al. Aspartame administered in feed, beginning prenatally through life span, induces cancers of the liver and lung in male Swiss mice. Am J Ind Med. 2010; 53(12): 1197-1206.

  69. Geha R, Buckley C, Greenberger P, Patterson R, Polmar S, Saxon A et al. Aspartame is no more likely than placebo to cause urticaria/angioedema: results of a multicenter, randomized, double-blind, placebo-controlled, crossover study. J Allergy Clin Immunol. 1993; 92(4): 513-520.

  70. Aguilar F, Crebelli R, Di Domenico A, Dusemund B, Frutos MJ, Galtier P et al. Statement on the validity of the conclusions of a mouse carcinogenicity study on sucralose (E 955) performed by the Ramazzini Institute. EFSA Journal. 2017; 15(5): 4784.

  71. Wilson BG, Bahna SL. Adverse reactions to food additives. Ann Allergy Asthma Immunol. 2005; 95(6): 499-507.

  72. Sugiura S, Kondo Y, Ito K, Hashiguchi A, Takeuchi M, Koyama N. A case of anaphylaxis to erythritol diagnosed by CD203c expression–based basophil activation test. Ann Allergy Asthma Immunol. 2013; 111(3): 222-223.

  73. Kimata H. Anaphylaxis by stevioside in infants with atopic eczema. Allergy. 2007; 62(5): 565-566.

  74. Urban JD, Carakostas MC, Taylor SL. Steviol glycoside safety: are highly purified steviol glycoside sweeteners food allergens? Food Chem Toxicol. 2015; 75: 71-78.

  75. Rajan JP, Simon RA, Bosso JV. Prevalence of sensitivity to food and drug additives in patients with chronic idiopathic urticaria. J Allergy Clin Immunol Pract. 2014; 2(2): 168-171.

  76. Maslova E, Strøm M, Olsen SF, Halldorsson TI. Consumption of artificially-sweetened soft drinks in pregnancy and risk of child asthma and allergic rhinitis. PloS One. 2013; 8(2): e57261.

  77. Sullivan JB, Krieger GR. Clinical environmental health and toxic exposures. Lippincott Williams & Wilkins; 2001, p. 1323.

  78. Magnuson BA, Burdock GA, Doull J, Kroes RM, Marsh GM, Pariza MW et al. Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Crit Rev Toxicol. 2007; 37: 629-727.

  79. Butchko HH, Stargel WW, Comer CP, Mayhew DA, Benninger C, Blackburn GL et al. Aspartame: review of safety. Regul Toxicol Pharmacol. 2002; 35(2 Pt 2): S1-93.

  80. Wolraich ML, Lindgren SD, Stumbo PJ, Stegink LD, Appelbaum MI, Kiritsy MC. Effects of diets high in sucrose or aspartame on the behavior and cognitive performance of children. N Engl J Med. 1994; 330(5): 301-307.

  81. Pinto JM, Maher TJ. Administration of aspartame potentiates pentylenetetrazole-and fluorothyl-induced seizures in mice. Neuropharmacology. 1988; 27(1): 51-55.

  82. Guiso G, Diomede L, Romano M, Caccia S, Sarati S, Salmona M. Effect of tyrosine on the potentiation by aspartame and phenylalanine of metrazol-induced convulsions in rats. Food Chem Toxicol. 1991; 29(12): 855-857.

  83. Tilson H, Thai L, Zhao D, Sobotka T, Hong J. Oral administration of aspartame is not proconvulsant in rats. Neurotoxicology. 1988; 10(2): 229-238.

  84. Cain DP, Boon F, Bevan M. Failure of aspartame to affect seizure susceptibility in kindled rats. Neuropharmacology. 1989; 28(4): 433-435.

  85. Magnuson B. Aspartame--facts and fiction. N Z Med J. 2010; 123(1311): 53-57.

  86. Sylvetsky AC, Gardner AL, Bauman V, Blau JE, Garraffo HM, Walter PJ et al. Nonnutritive sweeteners in breast milk. Journal of Toxicology and Environmental Health. 2015; 78(16): 1029-1032.

  87. Azad MB, Sharma AK, de Souza RJ, Dolinsky VW, Becker AB, Mandhane PJ et al. Association between artificially sweetened beverage consumption during pregnancy and infant body mass index. JAMA Pediatr. 2016; 170(7): 662-670.

  88. Borrajo GJ. Panorama epidemiológico de la fenilcetonuria (PKU) en Latinoamérica. Acta Pediatr Mex. 2012; 33(6): 279-287.

  89. Mackey SA, Berlin Jr CM. Effect of dietary aspartame on plasma concentrations of phenylalanine and tyrosine in normal and homozygous phenylketonuric patients. Clin Pediatr (Phila). 1992; 31(7): 394-399.

  90. Filer L, Stegink LD. Aspartame metabolism in normal adults, phenylketonuric heterozygotes, and diabetic subjects. Diabetes Care. 1989; 12(1): 67-74.

  91. Wolf-Novak LC, Stagink LD, Brummel MC, Persoon TJ, Filer L, Bell EF et al. Aspartame ingestion with and without carbohydrate in phenylketonuric and normal subjects: effect on plasma concentrations of amino acids, glucose, and insulin. Metabolism. 1990; 39(4): 391-396.

  92. Trefz F, de Sonneville L, Matthis P, Benninger C, Lanz-Englert B, Bickel H. Neuropsychological and biochemical investigations in heterozygotes for phenylketonuria during ingestion of high dose aspartame (a sweetener containing phenylalanine). Hum Genet. 1994; 93(4): 369-374.

  93. Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 2014; 514(7521): 181-186.

  94. Qin X. What made Canada become a country with the highest incidence of inflammatory bowel disease: Could sucralose be the culprit? Can J Gastroenterol. 2011; 25(9): 511.

  95. Petersen SB, Rasmussen MA, Olsen SF, Vestergaard P, Mølgaard C, Halldorsson TI et al. Maternal dietary patterns during pregnancy in relation to offspring forearm fractures: prospective study from the Danish national birth cohort. Nutrients. 2015; 7(4): 2382-2400.

  96. Nguyen UN, Dumoulin G, Henriet MT, Regnard J. Aspartame ingestion increases urinary calcium, but not oxalate excretion, in healthy subjects. J Clin Endocrinol Metab. 1998; 83(1): 165-168.

  97. Mandel I, Grotz V. Dental considerations in sucralose use. J Clin Dent. 2002; 13(3): 116-118.

  98. Meyerowitz C, Syrrakou EP, Raubertas RF. Effect of sucralose-alone or bulked with maltodextrin and/or dextrose--on plaque pH in humans. Caries Res. 1996; 30(6): 439-444.




2020     |     www.medigraphic.com